FREE SHIPPING ON ORDERS OVER $150

l-carnitine and cancer | Linus Pauling Institute A glutathione-responsive L-carnitine-modified camptothecin oral

$23.93

Quantity
- +
Description

At this time, we attribute the modulations of cobI and copA to the synergism between DDTC and these metals

l-carnitine and cancer | Linus Pauling Institute A glutathione-responsive L-carnitine-modified camptothecin oral

Ceram Soc

l-carnitine and cancer | Linus Pauling Institute A glutathione-responsive L-carnitine-modified camptothecin oral

While b 0,+ AT, also referred to as SLC7A9, is the main component for system b 0,+ and is expressed exclusively in the kidneys, xCT, which is referred to as SLC7A11, plays the main role in system x c [48,49]

l-carnitine and cancer | Linus Pauling Institute A glutathione-responsive L-carnitine-modified camptothecin oral

Identification of thioredoxin disulfide targets using a quantitative proteomics approach based on isotope-coded affinity tags

l-carnitine and cancer | Linus Pauling Institute A glutathione-responsive L-carnitine-modified camptothecin oral

simple phenolics such as, (gallic acid, caffeic acid, etc

l-carnitine and cancer | Linus Pauling Institute A glutathione-responsive L-carnitine-modified camptothecin oral

Membrane transporters in cell physiology, cancer metabolism and drug response

l-carnitine and cancer | Linus Pauling Institute A glutathione-responsive L-carnitine-modified camptothecin oral

You may also like

BPC-157

US$ 25.25

5.0 (6 reviews)

recommand products